CVG.F - CSPC Pharmaceutical Group Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures4

Market Cap (intraday) 10.22B
Enterprise Value 8.47B
Trailing P/E 12.46
Forward P/E 11.59
PEG Ratio (5 yr expected) 2.50
Price/Sales (ttm)2.45
Price/Book (mrq)2.51
Enterprise Value/Revenue 0.27
Enterprise Value/EBITDA 1.11

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-7.95%
S&P500 52-Week Change 31.77%
52 Week High 31.2535
52 Week Low 30.8360
50-Day Moving Average 30.8939
200-Day Moving Average 30.9979

Share Statistics

Avg Vol (3 month) 3849
Avg Vol (10 day) 3724
Shares Outstanding 511.9B
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 129.60%
% Held by Institutions 133.12%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 43.13%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.60
Payout Ratio 434.37%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 05, 2023
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Mar 31, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)2.60
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)2.53

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A